HopeStage
Back to all studies
RecruitingNCT06877858

Finding a methadone starting dose for opioid use with fentanyl

About this titleRead the official source — NCT06877858
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

What will I do during this study?

You start methadone on an inpatient research unit, with staff monitoring you closely. Random assignment determines whether you receive the usual starting regimen or a loading-dose regimen; both groups receive methadone.

Listed locations
PhiladelphiaSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 25, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
24
Sponsor
Ashish P Thakrar, MD MS
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06877858
Official title
Show the full official title

A Dose-Finding Study of Methadone Loading Dose Initiation for Opioid Use Disorder With Fentanyl Use

Recruitment & locations

Currently recruiting

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ashish P Thakrar, MD MS.

Does this study involve medication?

Yes. The study involves medication, including Methadone hydrochloride.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies